These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8960154

  • 1. Testicular toxicity evaluation of arsenic-containing binary compound semiconductors, gallium arsenide and indium arsenide, in hamsters.
    Omura M, Hirata M, Tanaka A, Zhao M, Makita Y, Inoue N, Gotoh K, Ishinishi N.
    Toxicol Lett; 1996 Dec 16; 89(2):123-9. PubMed ID: 8960154
    [Abstract] [Full Text] [Related]

  • 2. Testicular toxicity of gallium arsenide, indium arsenide, and arsenic oxide in rats by repetitive intratracheal instillation.
    Omura M, Tanaka A, Hirata M, Zhao M, Makita Y, Inoue N, Gotoh K, Ishinishi N.
    Fundam Appl Toxicol; 1996 Jul 16; 32(1):72-8. PubMed ID: 8812231
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of the toxic effects of gallium arsenide, indium arsenide and arsenic trioxide following intratracheal instillations to the lung of Syrian golden hamsters.
    Tanaka A, Hirata M, Omura M, Zhao M, Makita Y, Yamazaki K, Inoue N, Gotoh K.
    Fukuoka Igaku Zasshi; 2000 Jan 16; 91(1):21-33. PubMed ID: 10714013
    [Abstract] [Full Text] [Related]

  • 4. Comparative pulmonary toxicity of gallium arsenide, gallium(III) oxide, or arsenic(III) oxide intratracheally instilled into rats.
    Webb DR, Wilson SE, Carter DE.
    Toxicol Appl Pharmacol; 1986 Mar 15; 82(3):405-16. PubMed ID: 3952726
    [Abstract] [Full Text] [Related]

  • 5. Toxicity of indium arsenide, gallium arsenide, and aluminium gallium arsenide.
    Tanaka A.
    Toxicol Appl Pharmacol; 2004 Aug 01; 198(3):405-11. PubMed ID: 15276420
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metabolomic and proteomic biomarkers for III-V semiconductors: chemical-specific porphyrinurias and proteinurias.
    Fowler BA, Conner EA, Yamauchi H.
    Toxicol Appl Pharmacol; 2005 Aug 07; 206(2):121-30. PubMed ID: 15967200
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the male reproductive toxicity of gallium arsenide.
    Bomhard EM, Cohen SM, Gelbke HP, Williams GM.
    Regul Toxicol Pharmacol; 2012 Oct 07; 64(1):77-86. PubMed ID: 22728686
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxicity Assessment of Gallium- and Indium-Based Nanoparticles Toward Human Bronchial Epithelial Cells Using an Impedance-Based Real-Time Cell Analyzer.
    Nguyen CH, Zeng C, Boitano S, Field JA, Sierra-Alvarez R.
    Int J Toxicol; 2020 Oct 07; 39(3):218-231. PubMed ID: 32228215
    [Abstract] [Full Text] [Related]

  • 13. Microbial toxicity of gallium- and indium-based oxide and arsenide nanoparticles.
    Nguyen CH, Field JA, Sierra-Alvarez R.
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2020 Oct 07; 55(2):168-178. PubMed ID: 31607225
    [Abstract] [Full Text] [Related]

  • 14. In vitro solubility and in vivo toxicity of gallium arsenide.
    Webb DR, Sipes IG, Carter DE.
    Toxicol Appl Pharmacol; 1984 Oct 07; 76(1):96-104. PubMed ID: 6484996
    [Abstract] [Full Text] [Related]

  • 15. Selenium effects on gallium arsenide induced biochemical and immunotoxicological changes in rats.
    Flora SJ, Kannan GM, Kumar P.
    Chem Biol Interact; 1999 Aug 30; 122(1):1-13. PubMed ID: 10475611
    [Abstract] [Full Text] [Related]

  • 16. Metabolism and excretion of gallium arsenide and arsenic oxides by hamsters following intratracheal instillation.
    Rosner MH, Carter DE.
    Fundam Appl Toxicol; 1987 Nov 30; 9(4):730-7. PubMed ID: 3692028
    [Abstract] [Full Text] [Related]

  • 17. Metabolism of subcutaneous administered indium arsenide in the hamster.
    Yamauchi H, Takahashi K, Yamamura Y, Fowler BA.
    Toxicol Appl Pharmacol; 1992 Sep 30; 116(1):66-70. PubMed ID: 1529454
    [Abstract] [Full Text] [Related]

  • 18. Evidence for arsenic as the immunosuppressive component of gallium arsenide.
    Burns LA, Sikorski EE, Saady JJ, Munson AE.
    Toxicol Appl Pharmacol; 1991 Aug 30; 110(1):157-69. PubMed ID: 1651571
    [Abstract] [Full Text] [Related]

  • 19. Effect of intratracheal gallium arsenide administration on delta-aminolevulinic acid dehydratase in rats: relationship to urinary excretion of aminolevulinic acid.
    Goering PL, Maronpot RR, Fowler BA.
    Toxicol Appl Pharmacol; 1988 Feb 30; 92(2):179-93. PubMed ID: 3341032
    [Abstract] [Full Text] [Related]

  • 20. Co-administration of meso 2,3-dimercaptosuccinic acid monoesters reduces arsenic concentration and oxidative stress in gallium arsenide exposed rats.
    Flora SJ, Bhatt K, Dwivedi N, Pachauri V, Kushwah PK.
    Clin Exp Pharmacol Physiol; 2011 Jul 30; 38(7):423-9. PubMed ID: 21501211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.